Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast Cancer
Clinical trial NCT00712881 · COMPLETED
Trial details
- NCT number
- NCT00712881
- Sponsor
- Cephalon, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-13
- Primary completion
- 2015-09-17
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.